Literature DB >> 12835949

GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease.

I Ferrer1, B Puig.   

Abstract

The excitatory ionotropic glutamate receptors N-methyl- d-aspartate (NMDA) and alpha-amino-3-hydro-5methyl-4-isoxazole propionic acid (AMPA) receptors, and the inhibitory gamma-aminobutyric acid (GABA) receptors are major regulators of synaptic transmission in the central nervous system. Glutamate receptors AMPA GluR2/3 and NMDA R2A: NR2A (NMDAepsilon1), and GABA(A) (GABA(A) Ralpha1) receptors were examined by immunohistochemistry in the cerebral cortex (frontal cortex) entorhinal cortex, hippocampus and cerebellar cortex in nine patients with sporadic Creutzfeldt-Jakob disease (CJD) and eight age-matched controls obtained 3-8 h after death. All patients with CJD showed methionine/methionine in codon 129 of the prion protein gene. Decreased GluR2/3 immunoreactivity was found in the frontal cortex, entorhinal cortex and Purkinje cells; reduced NMDAepsilon1 immunoreactivity was found in the frontal cortex, entorhinal cortex, and molecular and granular cell layers of the cerebellum. Decreased GluR2/3 and NMDAepsilon1 immunoreactivity was also observed in the molecular layer of the dentate gyrus, but not in the hippocampus proper in cases with hippocampal involvement. GABA(A) Ralpha1 expression was markedly decreased in the granular cell layer of the cerebellum in CJD. Decreased GluR2/3 and NMDAepsilon1 expression correlated with prion protein deposition, neuron loss and spongiform degeneration in the cerebral cortex in every case. However, reduced GluR2/3 immunoreactivity in Purkinje cells was apparently independent of these parameters. In contrast to ionotropic glutamate receptors, GABA(A) Ralpha1 immunoreactivity was moderately increased in the frontal cortex, entorhinal cortex and molecular layer of the cerebellum in CJD. The present results show marked and selective abnormalities in the expression of crucial neurotransmitter receptors in CJD, ionotropic glutamate receptors being more severely affected than ionotropic GABA receptors. These findings stress selective vulnerability of glutamate receptors versus GABA receptors in CJD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835949     DOI: 10.1007/s00401-003-0732-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Detection of anti-glutamate receptor ε2 and anti-N-methyl-D: -aspartate receptor antibodies in a patient with sporadic Creutzfeldt-Jakob disease.

Authors:  Koji Fujita; Tatsuhiko Yuasa; Yukitoshi Takahashi; Keiko Tanaka; Shuji Hashiguchi; Katsuhito Adachi; Yuishin Izumi; Ryuji Kaji
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

Review 2.  NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease.

Authors:  Graham Mackay; Kate Ahmad; Jon Stone; Cathie Sudlow; David Summers; Richard Knight; Robert Will; Sarosh R Irani; Angela Vincent; Paul Maddison
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

Review 3.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

Review 4.  "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.

Authors:  K M O'Connor; G Barest; T Moritani; O Sakai; A Mian
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

Review 5.  Differential diagnosis of cerebral hemispheric pathology: multimodal approach.

Authors:  T Moritani; W R K Smoker; H K Lee; Y Sato
Journal:  Clin Neuroradiol       Date:  2011-04-29       Impact factor: 3.649

6.  Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease.

Authors:  Edward Málaga-Trillo; Katharina Ochs
Journal:  Prion       Date:  2016-09-02       Impact factor: 3.931

7.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

8.  Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity.

Authors:  Despoina Goniotaki; Asvin K K Lakkaraju; Amulya N Shrivastava; Pamela Bakirci; Silvia Sorce; Assunta Senatore; Rajlakshmi Marpakwar; Simone Hornemann; Fabrizio Gasparini; Antoine Triller; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2017-11-27       Impact factor: 6.823

9.  SK3 Channel Overexpression in Mice Causes Hippocampal Shrinkage Associated with Cognitive Impairments.

Authors:  Sabine Martin; Marcio Lazzarini; Christian Dullin; Saju Balakrishnan; Felipe V Gomes; Milena Ninkovic; Ahmed El Hady; Luis A Pardo; Walter Stühmer; Elaine Del-Bel
Journal:  Mol Neurobiol       Date:  2016-01-23       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.